Aids-Associated Viral Oncogenesis

Meyers, Craig

doi:10.1007/978-0-387-46816-7

Cancer Treatment and Research

2007

DOI: 10.1007/978-0-387-46816-7

|View full text |Cite

Aids-Associated Viral Oncogenesis

Craig Meyers¹

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 945 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Interim FDG-PET/CT as a predictor of prognosis for HIV-related malignant lymphoma: Preliminary study

Minamimoto

Tanuma

Morooka

et al. 2013

JST

View full text Add to dashboard Cite

Object: The aim of this retrospective study was to clarify the potential of fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) for predicting prognosis in HIV-related malignant lymphoma (ML). Methods: Participants comprised 24 patients (23 men, 1 woman; mean age, 42.2 years; range, 25-66 years) with histologically proven ML, classified as either diffuse large B-cell lymphoma (DLBCL) or Burkitt lymphoma according to the classification of the World Health Organization. We compared relationships between overall survival (OS) and several indices, including FDG uptake into the lesion site on pretreatment PET and findings on interim PET. Diagnostic criteria for response evaluation followed International Harmonization Project criteria. Results: Negative findings on interim PET were associated with significantly longer OS (932±549 days) compared to positive cases (454±442 days, p=0.043). Cox regression analysis showed strong prognostic influences of interim PET findings (Hazard ratio 4.57, 95%CI 0.88-23.73) and Eastern Cooperative Oncology Group performance status (Hazard ratio 10.52, 95%CI 1.26-87.82) on OS. No other indices showed significant relationships with OS. No significant correlation was confirmed between OS and both age and lesion uptake of FDG on pretreatment PET. Conclusion: HIV-related ML patients with negative findings on interim FDG-PET showed longer OS than patients with positive findings. Interim FDG-PET offers a predictor of prognosis for HIV-related ML.

show abstract

Interim FDG-PET/CT as a predictor of prognosis for HIV-related malignant lymphoma: Preliminary study

Minamimoto

Tanuma

Morooka

et al. 2013

JST

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Aids-Associated Viral Oncogenesis

Cited by 1 publication

References 945 publications

Interim FDG-PET/CT as a predictor of prognosis for HIV-related malignant lymphoma: Preliminary study

Interim FDG-PET/CT as a predictor of prognosis for HIV-related malignant lymphoma: Preliminary study

Contact Info

Product

Resources

About